Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
![Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11](https://ourvoice.werindia.com/wp-content/uploads/2021/09/Serum-Institute-Receives-Approval-To-Launch-Covovax-Trials-On-Children-Aged-7-11-OurVoice-WeRIndia.png)
Serum Institute of India has received permission to conduct clinical trials of Covovax among children aged 7 to 11 years.
According to reports, the SII-manufactured Novavax vaccine, Covovax, could be available for approval for use in children as early as January or February 2022.
.
Read more at: https://swarajyamag.com/news-brief/serum-institute-receives-approval-to-launch-covovax-trials-on-children-aged-7-11
.
Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |
- 30 Sep 2021
- WerIndia